Argenx, already deep into its Vyvgart launch, charts course to become immunology ‘powerhouse’: CEO
Argenx is off to the races with the launch of its new med Vyvgart.
With its first FDA-approved drug Vyvgart now rolling out, Argenx is charting a course to become an...